IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 166 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,252,000 | -73.6% | 119,300 | -76.1% | 0.14% | -74.2% |
| Q1 2017 | $8,516,000 | +11.6% | 499,200 | 0.0% | 0.54% | -14.3% |
| Q4 2016 | $7,632,000 | -15.4% | 499,200 | -12.1% | 0.63% | -14.1% |
| Q3 2016 | $9,021,000 | +99.4% | 568,100 | +64.1% | 0.73% | +72.8% |
| Q2 2016 | $4,525,000 | +109.2% | 346,100 | +75.0% | 0.42% | +93.2% |
| Q1 2016 | $2,163,000 | +68.6% | 197,800 | +78.7% | 0.22% | +34.4% |
| Q4 2015 | $1,283,000 | +154.1% | 110,700 | +127.8% | 0.16% | +147.0% |
| Q3 2015 | $505,000 | -79.9% | 48,600 | -76.7% | 0.07% | -81.2% |
| Q2 2015 | $2,511,000 | – | 208,400 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |